Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
KURA
— Kura Oncology, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 12, 2026
REVENUE
$18.3M
+5.4%
NET MARGIN
-401.5%
+65.7 PTS
EPS
-$0.83
+9.8%
FREE CASH FLOW
-$86.0M
-174.8%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →